Skip to main content

Table 3 Patients’ and clinicians’ utterance frequencies (n = 22 consultations)

From: How are emotional distress and reassurance expressed in medical consultations for people with long-term conditions who were unable to receive curative treatment? A pilot observational study with huntington’s disease and prostate cancer

Construct

Sample

Estimate of comparison (95%)

Code

Sub-domain

Huntington’s diseasea

Prostate cancera

Total

Mean per session

Patient emotional distress utterances

Cue A

11 (85%)

2 (15%)

13

0.59

.33 (.14, 1.50)

Cue B

14 (64%)

8 (36%)

22

1.00

.45 (.42, 1.51)

Cue C

6 (43%)

8 (57%)

14

0.64

.41 (1.05, .68)

Cue D

5 (100%)

0 (100%)

5

0.23

.16 (.10, .81)

Cue E

0 (N/A)

0 (N/A)

0

0.00

N/A

Cue F

1 (100%)

0 (0%)

1

0.05

.09 (.11, .29)

Cue G

15 (79%)

4 (21%)

19

0.86

.50 (.07, 2.07)

Cue total

52 (70%)

22 (30%)

74

3.36

.86 (.88, 4.57)

Concern

19 (79%)

5 (21%)

24

1.09

.55 (.11, 2.44)

Patient-elicited

46 (69%)

21 (31%)

67

3.05

1.01 (.10, 4.44)

Clinician-elicited

25 (81%)

6 (19%)

31

1.41

.48 (.71, 2.74)

Cues/concerns total

71 (72%)

27 (28%)

98

4.45

1.08 (1.74, 6.26)

Clinician emotional distress response utterances

Non-explicit

31 (76%)

10 (24%)

41

1.86

.65 (.51, 3.31)

Explicit

40 (70%)

17 (30%)

57

2.59

.86 (.30, 3.88)

Space-providing

54 (73%)

20 (27%)

74

3.36

.92 (1.18, 5.00)

Space-reducing

17 (71%)

7 (29%)

24

1.09

.48 (.09, 1.91)

Responses total

71 (72%)

27 (28%)

98

4.45

1.08 (1.74, 6.26)

Clinician spontaneous reassurance utterances

Affective reassurance

11 (35%)

20 (65%)

31

1.5

.48 (1.83, .19)

Cognitive reassurance

32 (39%)

51 (61%)

83

3.77

.71 (−3.22, −.23)

Reassurance total

43 (38%)

71 (62%)

114

5.18

.82 (−4.25, −.84)

  1. aFrequency: raw number (percent total frequency)